Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
SEC priorities for asset management industry
David Tittsworth, Ropes & Gray investment management counsel, examines what’s changed for the asset management industry under the Trump administration and what to expect during 2018.
Behavioral sciences approach to risk management
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
Impact of environmental, social and governance agenda on tax
Andrew Howard, Ropes & Gray tax partner, addresses tax coming out of the shadows and becoming part of an environmental, social and governance (ESG) agenda.
Enforcement of electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, addresses an emerging trend in the electronic health records space, where a number of companies are being investigated under the False Claims Act.
SEC activity with fixed income and credit funds
Dan O’Connor, co-leader of Ropes & Gray’s securities & futures enforcement practice, addresses the recent uptick in how the SEC is approaching issues at fixed income and credit funds.
International trade developments
Ama Adams, Ropes & Gray litigation & enforcement partner, discusses the complex array of trade laws and regulations facing companies with international operations.